insights_auto
Outlook: 68.6% bullish·0.0% bearish
Go to analysischevron_right
EW:NYSE
Edwards Lifesciences Corp
103,55 USD
arrow_downward
-1,11%(-1,16) 1D
10-ноя., 09:51:11 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
104,25 USD
High
104,58 USD
Low
103,54 USD
Mkt. cap
59,54 млд
Avg. vol.
4,48 млн
Volume
96,84 миң
P/E ratio
58,71
52-wk high
104,58 USD
52-wk low
74,66 USD
EPS
1,76 USD
Beta
0,85
Shares outstanding
575,00 млн
No. of employees
16 миң
Open
104,25 USD
High
104,58 USD
Low
103,54 USD
Mkt. cap
59,54 млд
Avg. vol.
4,48 млн
Volume
96,84 миң
P/E ratio
58,71
52-wk high
104,58 USD
52-wk low
74,66 USD
EPS
1,76 USD
Beta
0,85
Shares outstanding
575,00 млн
No. of employees
16 миң
News stories
From web sources and news partners
Trefis
·
7 саат мурун
6 Green Days In A Row: Edwards Lifesciences Stock Is Up 14%
Investing.com Canada
·
16 саат мурун
Form 144 Edwards Lifesciences Corp For: 9 November By Investing.com
News Corp
·
17 саат мурун
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com
·
23 саат мурун
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 миң
Founded1958
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteedwards.com